IR@PKUHSC  > 北京大学基础医学院  > 细胞生物学系
学科主题基础医学
LAPTM4B-35 Is a Novel Prognostic Factor of Hepatocellular Carcinoma
Yang, Hua1; Xiong, Fuxia1; Qi, Ruizhao2; Liu, Zhenwen2; Lin, Ming1; Rui, Jingan2; Su, Jing3; Zhou, Rouli1
关键词lysosomal protein transmembrane 4 beta (LAPTM4B) Western blot immunohistochemistry (IHC) hepatocellular carcinoma (HCC) prognosis
刊名JOURNAL OF SURGICAL ONCOLOGY
2010-04-01
DOI10.1002/jso.21489
101期:5页:363-369
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Surgery
研究领域[WOS]Oncology ; Surgery
关键词[WOS]LIVER-DISEASE ; PHASE-II ; CANCER ; EXPRESSION ; SORAFENIB ; ERLOTINIB ; RESECTION ; THERAPY ; PROTEIN ; MARKER
英文摘要

Background: LAPTM4B-35 is a 35-kDa tetra-transmembrane protein overexpressed in hepatocellular carcinoma (HCC) and promotes cell survival, proliferation, and tumorigenesis. However, the potential clinical implications of LAPTM4B-35 in HCC are still unclear. This study is aimed to investigate the correlations between LAPTM4B-35 expression and prognosis in patients with HCC.

Methods: Western blot and immunohistochemistry assays were used to determine the expression of LAPTM4B-35 in HCCs and their paired noncancerous liver tissues from 65 patients. The correlations of LAPTM4B-35 expression with clinicopathological parameters were assessed by Chi-square test. Patient survival was determined by Kaplan-Meier method and log-rank test. Cox regression was adopted for multivariate analysis of prognostic factors.

Results: LAPTM4B-35 overexpression occurred in 76.9% of HCC tissues, while only in 4.6% of noncancerous liver tissues. Overexpression of LAPTM4B-35 was significantly associated with TNM staging and invasive tumors. Patients with higher LAPTM4B-35 expression had significantly poorer overall survival (OS) and disease-free survival (DFS) (both P < 0.001). On multivariate analysis, elevated expression of LAPTM4B-35 was found to be an independent prognostic factor for OS and DFS (P = 0.009, 0.043, respectively).

Conclusions: LAPTM4B-35 overexpression is an independent prognostic factor for OS and DFS of HCC. J. Surg. Oncol. 2010;101:363-369. (C) 2010 Wiley-Liss, Inc.

语种英语
WOS记录号WOS:000276858500004
Citation statistics
Cited Times:36[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60419
Collection北京大学基础医学院_细胞生物学系
北京大学基础医学院
作者单位1.Peking Univ, Dept Cell Biol, Sch Basic Med Sci, Beijing 100191, Peoples R China
2.302 Hosp Peoples Liberat Army, Dept Liver & Gallbladder Surg, Beijing, Peoples R China
3.Peking Univ, Dept Pathol, Sch Basic Med Sci, Beijing 100191, Peoples R China
Recommended Citation
GB/T 7714
Yang, Hua,Xiong, Fuxia,Qi, Ruizhao,et al. LAPTM4B-35 Is a Novel Prognostic Factor of Hepatocellular Carcinoma[J]. JOURNAL OF SURGICAL ONCOLOGY,2010,101(5):363-369.
APA Yang, Hua.,Xiong, Fuxia.,Qi, Ruizhao.,Liu, Zhenwen.,Lin, Ming.,...&Zhou, Rouli.(2010).LAPTM4B-35 Is a Novel Prognostic Factor of Hepatocellular Carcinoma.JOURNAL OF SURGICAL ONCOLOGY,101(5),363-369.
MLA Yang, Hua,et al."LAPTM4B-35 Is a Novel Prognostic Factor of Hepatocellular Carcinoma".JOURNAL OF SURGICAL ONCOLOGY 101.5(2010):363-369.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Yang, Hua]'s Articles
[Xiong, Fuxia]'s Articles
[Qi, Ruizhao]'s Articles
百度学术
百度学术Similar articles in
[Yang, Hua]'s Articles
[Xiong, Fuxia]'s Articles
[Qi, Ruizhao]'s Articles
必应学术
必应学术Similar articles in
[Yang, Hua]'s Articles
[Xiong, Fuxia]'s Articles
[Qi, Ruizhao]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.